EVIDENCE PAN-EUROPEAN STUDY: NSAID USERS WITH RHEUMATIC DISEASES, OVERVIEW OF PATIENTS CHARACTERISTICS AND MANAGEMENT

(1) UNIVERSITY HOSPITAL, I+CS. CIBEREHD

(2) VU University Medical Center

(3) AstraZeneca



This item was part of the Oesophageal, Gastric and Duodenal Disorders I session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A153